Relationship of measles vaccination with anaemia and malaria in western Kenya

Tropical Medicine and International Health

Volumn 10, Issue 11, 2005, Pages 1099-1107

  Desai, Meghna R ^a,c,d,f   Holtz, Timothy H ^a,g   Helfand, Rita ^b   Terlouw, Dianne J ^a,c,d,h   Wannemuehler, Kathleen A ^a,f   Kariuki, Simon K ^c   Shi, Ya Ping ^a,c,f   Nahlen, Bernard L ^e   Ter Kuile, Feiko O ^a,c,d,h  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^g NCHSTP   (United States)

^h LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

Author keywords

Africa; Anaemia; Haemoglobin; Kenya; Malaria; Measles vaccine

Indexed keywords

HEMOGLOBIN; MEASLES VACCINE;

ANEMIA; MALARIA; MEASLES; VACCINATION;

ACTIVE IMMUNIZATION; ANEMIA; ARTICLE; CELLULAR IMMUNITY; COHORT ANALYSIS; CONFIDENCE INTERVAL; DISEASE SEVERITY; ENDEMIC DISEASE; FEMALE; HUMAN; INFANT; KENYA; MALARIA; MALE; MEASLES VACCINATION; PARASITEMIA; PRESCHOOL CHILD; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VIRUS INFECTION;

ANEMIA; CELL SIZE; FEMALE; HEMOGLOBINS; HUMANS; INFANT; KENYA; MALARIA; MALE; MEASLES; MEASLES VACCINE; PARASITEMIA; RETROSPECTIVE STUDIES; VACCINATION; VACCINES, ATTENUATED;

AFRICA; EAST AFRICA; KENYA; SUB-SAHARAN AFRICA;

MEASLES VIRUS;

EID: 27844531551     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2005.01494.x     Document Type: Article

References (41)

1. Beier JC, Oster CN, Onyango FK, Bales JD, Sherwood JA, Perkins PV et al. (1994) Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. American Journal of Tropical Medicine and Hygiene 50, 529-536.
2. Bloland PB, Boriga DA, Ruebush TK, McCormick JB, Roberts JM, Oloo AJ et al. (1999a) Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission II. Descriptive epidemiology of malaria infection and disease among children. American Journal of Tropical Medicine and Hygiene 60, 641-648.
3. Bloland PB, Ruebush TK, McCormick JB, Ayisi J, Boriga DA, Oloo AJ et al. (1999b) Longitudinal cohort study of the epidemiology of malaria infections in an area of intense malaria transmission I. Description of study site, general methodology, and study population. American Journal of Tropical Medicine and Hygiene 60, 635-640.
4. Brabin BJ, Premji Z & Verhoeff F (2001) An analysis of anemia and child mortality. Journal of Nutrition 131, 636-645; discussion 646-648.
5. Bradley-Moore AM, Greenwood BM, Bradley AK, Bartlett A, Bidwell DE, Voiler A et al. (1985) Malaria chemoprophylaxis with chloroquine in young Nigerian children. II. Effect on the immune response to vaccination. Annals Tropical Medicine and Parasitology 79, 563-573.
6. Brody J & McAlister R (1964) Depression of tuberculin sensitivity following measles vaccination. American Review of Respiratory Disease 90, 607-611.
7. Cenac A, Develoux M & Djibo A (1988) Chloroquine treatment of malaria does not increase antibody response to measles vaccination. A controlled study of 580 rural children living in an endemic malaria area. Transaction of the Royal Society Tropical Medicine Hygiene 82, 405.
8. Desai MR, Dhar R, Rosen DH, Kariuki SK, Shi YP, Kager PA et al. (2004) Daily iron supplementation is more efficacious than twice weekly iron supplementation for the treatment of childhood anemia in western Kenya. Journal of Nutrition 134, 1167-1174.
9. Desai MR, Mei JV, Kariuki SK, Wannemuehler KA, Phillips-Howard PA, Nahlen BL et al. (2003) Randomized, Controlled Trial of Daily Iron Supplementation and Intermittent Sulfadoxine-Pyrimethamine for the Treatment of Mild Childhood Anemia in Western Kenya. Journal of Infectious Disease 187, 658-666.
10. Fireman P, Friday G & Kumate J (1969) Effect of measles vaccine on immunologic responsiveness. Pediatrics 43, 264-272.
11. Gans HA, Maldonado Y, Yasukawa LL, Beeler J, Audet S, Rinki MM et al. (1999) IL-12, IFN-gamma, and T cell proliferation to measles in immunized infants. Journal of Immunology 162, 5569-5575.
12. GAVI Annual deaths from vaccine-preventable diseases, 2001: WHO estimates. Available at: http://www.vaccinealliance.org/ home/ General_Information/Immunization_informa/ Diseases_Vaccines/ vaccine_preventable_deaths.php). Accessed 16 Dec 2003.
13. Gimnig JE, Kolczak MS, Hightower AW, Vulule JM, Schoute E, Kamau L et al. (2003a) Effect of Permethrin-Treated Bed Nets on the Spatial Distribution of Malaria Vectors in Western Kenya. American Journal of Tropical Medicine and Hygiene 68, 115-120.
14. Gimnig JE, Vulule JM, Lo TQ, Kamau L, Kolczak MS, Phillips-Howard PA et al. (2003b) Impact of permethrin-treated bednets on entomologic indices in an area of intense year-round malaria transmission. American Journal of Tropical Medicine and Hygiene 68, 16-22.
15. Hildreth E, Frederic M & Randall P (1963) Alterations in delayed hypersensitivity produced by live attenuated measles virus in man. Transactions of the American Clinical and Climatological Association 75, 37-51.
16. Kantoch M, Abramow-Newerly W, Jankowski M, Imbs D, Litwinska B, Stepien R et al. (1980) Cell-mediated immune reactions in measles. Acta Virologica 24, 119-126.
17. Kwiatkowski D (1989) Febrile temperatures can synchronize the growth of Plasmodium falciparum in vitro. Journal of Experimental Medicine 169, 357-361.
18. Lindblade KA, Odhiambo F, Rosen DH & DeCock KM (2003) Health and nutritional status of orphans <6 years old cared for by relatives in western Kenya. Tropical Medicine and International Health 8, 67-72.
19. McElroy PD, Lal AA, Hawley WA, Bloland PB, Kuile FO, Oloo AJ et al. (1999) Analysis of repeated hemoglobin measures in full-term, normal birth weight Kenyan children between birth and four years of age. III. The Asembo Bay Cohort Project. American Journal of Tropical Medicine and Hygiene 61, 932-940.
20. McElroy PD, Kuile FO, ter Hightower AW, Hawley WA, Phillips-Howard PA, Oloo AJ et al. (2001) All-cause mortality among young children in western Kenya. VI: the Asembo Bay Cohort Project. American Journal of Tropical Medicine and Hygiene 64, 18-27.
21. The Measles Initiative. (2003) Available at: http://www. measlesinitiative.org. Accessed 16 Dec 2003.
22. Mellman W & Wetton R (1963) Depression of the tuberculin reaction by attenuated measles virus vaccine. Journal of Laboratory and Clinical Medicine 61, 453-458.
23. Meltzer MI, Terlouw DJ, Kolczak MS, Odhacha A, ter Kuile FO, Vulule JM et al. (2003) The household-level economics of using permethrin-treated bednets to prevent malaria in children under 5 years of age. American Journal of Tropical Medicine and Hygiene 68, 149-160.
24. MOH (1998) National Guidelines for diagnosis, treatment & prevention of malaria for health workers. Nairobi, Kenya.
25. Morley D (1969) Severe measles in the tropics. British Medical Journal 1, 297-300 contd.
26. Okada H, Sato TA, Katayama A, Higuchi K, Shichijo K, Tsuchiya T et al. (2001) Comparative analysis of host responses related to immunosuppression between measles patients and vaccine recipients with live attenuated measles vaccines. Archives of Virology 146, 859-874.
27. Olivares M, Walter T, Osorio M, Chadud P & Schlesinger L (1989) Anemia of a mild viral infection: the measles vaccine as a model. Pediatrics 84, 851-855.
28. Phillips-Howard PA, Nahlen BL, Kolczak MS, Hightower AW, ter Kuile FO, Alaii JA et al. (2003) Efficacy of permethrin-treated bednets in the prevention of mortality in young children in an area of high perennial malaria transmission in western Kenya. American Journal of Tropical Medicine and Hygiene 68, 23-29.
29. Pless RP, Bentsi-Enchill AD & Duclos P (2003) Monitoring vaccine safety during measles mass immunization campaigns: clinical and programmatic issues. Journal of Infectious Disease 187 (Suppl. 1), 291-298.
30. Rooth I, Sinani HM, Smedman L & Bjorkman A (1991) A study on malaria infection during the acute stage of measles infection. Journal of Tropical Medicine and Hygiene 94, 195-198.
31. Rosen JB, Breman JG, Manclark CR & Miller MA 2003 Does malaria have an immunosuppressive effect on the serologic response to measles and diphtheria-tetanus-pertussis vaccines? Conference of the American Society of Tropical Medicine and Hygiene, Philadelphia. Abstract 7.
32. Schellenberg D, Menendez C, Kahigwa E, Aponte J, Vidal J, Tanner M et al. (2001) Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo- controlled trial. Lancet 357, 1471-1477.
33. Schnorr JJ, Xanthakos S, Keikavoussi P, Kampgen E, ter Meulen V & Schneider-Schaulies S (1997) Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proceedings of the National Academy of Sciences of the United States of America 94, 5326-5331.
34. Scrimshaw NS & SanGiovanni JP (1997) Synergism of nutrition, infection, and immunity: an overview. American Journal of Clinical Nutrition 66, 464-477.
35. Starr S & Berkovich S (1964) Effects of measles, gamma-globulin- modified measles and vaccine measles on the tuberculin test. New England Journal of Medicine 270, 386-391.
36. Stein CE, Birmingham M, Kurian M, Duclos P & Strebel P (2003) The global burden of measles in the year 2000 - a model that uses country-specific indicators. Journal of Infectious Disease 187 (Suppl. 1), 8-14.
37. Tamashiro VG, Perez HH & Griffin DE (1987) Prospective study of the magnitude and duration of changes in tuberculin reactivity during uncomplicated and complicated measles. Pediatrics Infectious Disease Journal 6, 451-454.
38. ter Kuile FO, Terlouw DJ, Phillips-Howard PA, Hawley WA, Friedman JF, Kolczak MS et al. (2003) Impact of permethrin-treated bednets on malaria and all cause morbidity in young children in an area of intense perennial malaria transmission in western Kenya: cross-sectional survey. American Journal of Tropical Medicine and Hygiene 68, 100-107.
39. Ward BJ & Griffin DE (1993) Changes in cytokine production after measles virus vaccination: predominant production of IL-4 suggests induction of a Th2 response. Clinical Immunology and Immunopathology 67, 171-177.
40. Whittle HC, Dossetor J, Oduloju A, Bryceson AD & Greenwood BM (1978) Cell-mediated immunity during natural measles infection. Journal of Clinical Investigation 62, 678-684.
41. Whittle HC, Mee J, Werblinska J, Yakubu A, Onuora C & Gomwalk N (1980) Immunity to measles in malnourished children. Clinical and Experimental Immunology 42, 144-151.